GILD ▲ +7.0% - Gilead Sciences, Inc. $GILD | Gilead Sciences Q3 Earnings: - Net Income: $2,429M - Product Sales: $8,289M - EPS: $1.94 - Adjusted EPS: $2.55 (est $2.19) - Sees FY Adjusted EPS: -$1.2 To -$0.85 - Sees FY Product Sales: $31,000M-$31,300M - FY GAAP And Adjusted Loss Per Share Outlook Includes Impact Of About $9.88 From Acquired $12.4B IPR&D Charges 29-OCT-2026 04:24 PM ET